Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016–2017

Haiti is striving for zero local malaria transmission by the year 2025. Chloroquine remains the first-line treatment, and sulfadoxine/pyrimethamine (SP) has been used for mass drug-administration pilot programs. In March 2016, nationwide molecular surveillance was initiated to assess molecular resis...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Eric Rogier, Camelia Herman, Curtis S. Huber, Karen E.S. Hamre, Baby Pierre, Kimberly E. Mace, Jacquelin Présumé, Gina Mondélus, Ithamare Romilus, Tamara Elismé, Thomas P. Eisele, Thomas Druetz, Alexandre Existe, Jacques Boncy, Jean F. Lemoine, Venkatachalam Udhayakumar, Michelle A. Chang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Centers for Disease Control and Prevention 2020-05-01
coleção:	Emerging Infectious Diseases
Assuntos:	Plasmodium falciparum Haiti drug resistance chloroquine sulfadoxine pyrimethamine
Acesso em linha:	https://wwwnc.cdc.gov/eid/article/26/5/19-0556_article
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!